These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 4024529)
1. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals]. Kudriashov BA; Pastorova VE; Liapina LA Vopr Med Khim; 1985; 31(3):37-41. PubMed ID: 4024529 [TBL] [Abstract][Full Text] [Related]
2. [Effect of multiple intravenous injections of heparin on the content of antithrombin III in healthy animals and experimental atherosclerosis]. Kudriashov BA; Pastorova VE; Bazaz'ian GG; Liapina LA Vopr Med Khim; 1984; 30(1):82-6. PubMed ID: 6710943 [TBL] [Abstract][Full Text] [Related]
3. [Anticoagulant and nonenzymatic fibrinolytic activity of plasma in animals after intravenous injection of a heparin-antithrombin III complex]. Kudriashov BA; Pastorova VE; Liapina LA Biull Eksp Biol Med; 1985 Jan; 99(1):62-4. PubMed ID: 3967074 [TBL] [Abstract][Full Text] [Related]
4. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo. Kudrjashov BA; Pastorova VE; Lyapina LA Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257 [TBL] [Abstract][Full Text] [Related]
5. Influence of hirudin on the consumption of antithrombin III in experimental DIC. Hauptmann J; Brüggener E Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037 [TBL] [Abstract][Full Text] [Related]
6. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy]. von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907 [TBL] [Abstract][Full Text] [Related]
7. Plasma heparin values and hemostasis in equids after subcutaneous administration of low-dose calcium heparin. Gerhards H; Eberhardt C Am J Vet Res; 1988 Jan; 49(1):13-8. PubMed ID: 3354959 [TBL] [Abstract][Full Text] [Related]
8. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog. Hellebrekers LJ; Slappendel RJ; van den Brom WE Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027 [TBL] [Abstract][Full Text] [Related]
9. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system]. Kudriashov BA; Liapina LA; Pastorova VE Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189 [TBL] [Abstract][Full Text] [Related]
10. Adverse effect of heparin in thrombin-antithrombin III interaction. Marciniak E Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544 [TBL] [Abstract][Full Text] [Related]
11. [Antithrombin III inhibition of the reaction to thrombin excitation of the anticoagulation system]. Strukova SM; Umarova BA; Golubeva MG; Dugina TN; Bashkov GV Biull Eksp Biol Med; 1987 Mar; 103(3):268-70. PubMed ID: 3828498 [TBL] [Abstract][Full Text] [Related]
12. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes. Flather MD; Weitz JI; Yusuf S; Pogue J; Sussex B; Campeau J; Gill J; Schuld R; Joyner CD; Morris AL; Lai C; Théroux P; Marquis JF; Chan YK; Venkatesh G; Jessel A Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840 [TBL] [Abstract][Full Text] [Related]
13. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin]. Kudriashov BA; Pastorova VE; Liapina LA Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530 [TBL] [Abstract][Full Text] [Related]
14. Long duration of anticoagulant activity and protective effects of acharan sulfate in vivo. Li DW; Lee IS; Sim JS; Toida T; Linhardt RJ; Kim YS Thromb Res; 2004; 113(1):67-73. PubMed ID: 15081567 [TBL] [Abstract][Full Text] [Related]
15. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate]. Ono I Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736 [TBL] [Abstract][Full Text] [Related]
16. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency. Herren T; Straub PW; Haeberli A Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646 [TBL] [Abstract][Full Text] [Related]
17. [Effect of the nerve growth factor on blood coagulation and fibrinolysis]. Isanbaev ChI; Vypova NL; Kazantseva DS; Sagdiev N Eksp Klin Farmakol; 1997; 60(3):45-7. PubMed ID: 9324398 [TBL] [Abstract][Full Text] [Related]
18. The monitoring of heparin administration by screening tests in experimental dogs. Mischke R; Jacobs C Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088 [TBL] [Abstract][Full Text] [Related]
19. [Perioperative plasma antithrombin activity with "low-dose" heparin prophylaxis. Perioperatively acquired antithrombin III deficiency as a cause for the failure of heparin prophylaxis?]. Kussmann J; Hirche H; Sengupta R Dtsch Med Wochenschr; 1983 Mar; 108(12):449-52. PubMed ID: 6832015 [TBL] [Abstract][Full Text] [Related]
20. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration. Sié P; Lansen J; Lacheretz F; Verschuere B; Boneu B Thromb Haemost; 1986 Dec; 56(3):302-7. PubMed ID: 2436331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]